1. Home
  2. STRS vs OABI Comparison

STRS vs OABI Comparison

Compare STRS & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$29.47

Market Cap

238.1M

Sector

Real Estate

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.65

Market Cap

237.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
OABI
Founded
1992
2012
Country
United States
United States
Employees
N/A
89
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.1M
237.4M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
STRS
OABI
Price
$29.47
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
29.4K
657.9K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
512.50
N/A
EPS
1.47
N/A
Revenue
$29,914,000.00
N/A
Revenue This Year
N/A
$52.42
Revenue Next Year
N/A
$64.69
P/E Ratio
$20.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.35
$1.22
52 Week High
$32.93
$2.22

Technical Indicators

Market Signals
Indicator
STRS
OABI
Relative Strength Index (RSI) 47.38 61.96
Support Level $29.50 $1.47
Resistance Level $31.62 $1.70
Average True Range (ATR) 0.59 0.08
MACD -0.03 0.03
Stochastic Oscillator 56.54 89.71

Price Performance

Historical Comparison
STRS
OABI

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: